AFNAS
REGN icon

American Financial Network Advisory Services’s Regeneron Pharmaceuticals REGN Stock Holding History

American Financial Network Advisory Services’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-18
Closed -$8K – 741
2017
Q3 		$8K Buy
+18
New +$8.56K ﹤0.01% 520

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return

American Financial Network Advisory Services's REGN Position: Q4 2017 in Review

American Financial Network Advisory Services sold out of Regeneron Pharmaceuticals (REGN) in Q4 2017, closing a stake of 18 shares — an estimated $8K sold.

American Financial Network Advisory Services first reported a position in REGN in Q3 2017 and held it in 1 quarter. The position peaked at $8K in Q3 2017. 639 funds tracked by Wall St. Rank hold REGN as of Q4 2017.

  • American Financial Network Advisory Services reported no remaining Regeneron Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • American Financial Network Advisory Services sold 18 Regeneron Pharmaceuticals shares in Q4 2017, an estimated $8K.
  • American Financial Network Advisory Services first reported a position in Regeneron Pharmaceuticals in Q3 2017 and held it in 1 quarter.
  • American Financial Network Advisory Services's Regeneron Pharmaceuticals position peaked at $8K in Q3 2017.
  • 639 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2017.

Based on American Financial Network Advisory Services's 13F filing for Q4 2017, filed 2 Jan 2018.